Biotech veteran Jeff Jonas on leaving Sage, guiding new biotechs and his ‘personal odyssey’
Bio Pharma Dive
DECEMBER 6, 2022
In an interview with BioPharma Dive, the longtime industry executive discussed becoming a biotech investor and his plans for Abio-X, a new incubator with $150 million to spend on startups.
Let's personalize your content